niacinamide has been researched along with jnj-47965567 in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Aluisio, L; Ao, H; Bhattacharya, A; Bonaventure, P; Fraser, I; Letavic, MA; Lord, B; Lovenberg, TW; Neff, RA; Nepomuceno, D; Shoblock, JR; Wang, Q; Welty, N; Wickenden, AD | 1 |
| Alves, M; Arribas-Blázquez, M; Artalejo, AR; Bhattacharya, A; Conroy, RM; Delanty, N; Diaz-Hernandez, M; Engel, T; Farrell, MA; Henshall, DC; Jimenez-Pacheco, A; Letavic, M; Miras-Portugal, MT; O'Brien, DF; Olivos-Oré, LA; Sanz-Rodriguez, A | 1 |
| Bhattacharya, A; Calovi, S; Csölle, C; Haller, J; Hanuska, A; Kató, E; Köles, L; Koványi, B; Sperlágh, B | 1 |
| Bucolo, C; Di Paola, L; Drago, F; Giurdanella, G; Leggio, GM; Platania, CBM; Salomone, S | 1 |
| Bucolo, C; Conti, F; Drago, F; Fidilio, A; Fresta, CG; Giurdanella, G; Lazzara, F; Leggio, GM; Platania, CBM; Salomone, S | 1 |
| Amato, R; Bucolo, C; Chou, TH; Drago, F; Lazzara, F; Porciatti, V; Romano, GL | 1 |
| Chen, M; Guo, M; Huang, H; Li, Z; Lu, M; Wang, J; Xie, L; Zheng, S; Zhu, X | 1 |
7 other study(ies) available for niacinamide and jnj-47965567
| Article | Year |
|---|---|
Pharmacological characterization of a novel centrally permeable P2X7 receptor antagonist: JNJ-47965567.
Topics: Adenosine Triphosphate; Analgesics; Animals; Antidepressive Agents; Antimanic Agents; Behavior, Animal; Binding, Competitive; Bipolar Disorder; Blood-Brain Barrier; Brain; Calcium Signaling; Capillary Permeability; Cell Line; Depression; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Humans; Interleukin-1beta; Macaca; Male; Mice; Mice, Inbred C57BL; Neuralgia; Niacinamide; Piperazines; Protein Binding; Purinergic P2X Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2X7; Time Factors; Transfection | 2013 |
Transient P2X7 Receptor Antagonism Produces Lasting Reductions in Spontaneous Seizures and Gliosis in Experimental Temporal Lobe Epilepsy.
Topics: Adenosine Triphosphate; Adolescent; Adult; Animals; Brain; Calcium-Binding Proteins; Disease Models, Animal; Epilepsy, Temporal Lobe; Gene Expression Regulation; Gliosis; Green Fluorescent Proteins; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microfilament Proteins; Middle Aged; Nerve Tissue Proteins; Niacinamide; Piperazines; Platelet Aggregation Inhibitors; Purinergic P2X Receptor Antagonists; Receptors, Purinergic P2X7; Seizures; Up-Regulation; Young Adult | 2016 |
The role of P2X7 receptors in a rodent PCP-induced schizophrenia model.
Topics: Animals; Behavior, Animal; Cerebral Cortex; Mice; Mice, Knockout; Niacinamide; Phencyclidine; Piperazines; Purinergic P2X Receptor Antagonists; Pyramidal Cells; Receptors, Purinergic P2X7; Schizophrenia | 2016 |
P2X7 receptor antagonism: Implications in diabetic retinopathy.
Topics: Allosteric Site; Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Biomarkers; Cells, Cultured; Computational Biology; Databases, Chemical; Databases, Protein; Diabetic Retinopathy; Expert Systems; Humans; Ligands; Models, Molecular; Molecular Conformation; Molecular Docking Simulation; Niacinamide; Pericytes; Piperazines; Purinergic P2X Receptor Antagonists; Receptors, Purinergic P2X7; ROC Curve; Structural Homology, Protein | 2017 |
Blood-retinal barrier protection against high glucose damage: The role of P2X7 receptor.
Topics: Blood-Retinal Barrier; Cell Line; Endothelial Cells; Glucose; Humans; Niacinamide; Piperazines; Receptors, Purinergic P2X7; Retina; Tight Junctions | 2019 |
P2X7 receptor antagonism preserves retinal ganglion cells in glaucomatous mice.
Topics: Animals; Electroretinography; Glaucoma; Mice; Mice, Inbred DBA; Niacinamide; Piperazines; Purinergic P2X Receptor Antagonists; Receptors, Purinergic P2X7; Retinal Ganglion Cells | 2020 |
The potential of the P2X7 receptor as a therapeutic target in a sub-chronic PCP-induced rodent model of schizophrenia.
Topics: Animals; Animals, Newborn; Drug Delivery Systems; Hallucinogens; Injections, Subcutaneous; Male; Mice; Mice, Inbred C57BL; Niacinamide; Phencyclidine; Piperazines; Purinergic P2X Receptor Antagonists; Receptors, Purinergic P2X7; Rodentia; Schizophrenia | 2021 |